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ABSTRACT 
Background  and  Objective:  Carbapenems  are  therapeutic  choice  against  infections  caused  by  gram-negative  bacilli 
including strains of Acinetobacter baumannii. Resistance to these antibiotics is mediated by efflux pumps, porins, PBPs and 
ß-lactamases. The aim of this study was to determine the possibility of existence of MBLs, OXAs and GES-1 betalactamase 
genes among clinical isolates of Acinetobacter collected from Tehran hospitals.  
Material and Methods: Two hundred and three Acinetobacter isolates were collected from patient at Tehran hospitals. The 
isolates were identified using biochemical tests. The susceptibility to different antibiotics was evaluated by disk diffusion 
method and MICs of imipenem were determined using Micro broth dilution method (CLSI). PCR was performed for detection 
of blaVIM-2, blaSPM-1, blaIMP-2, blaGES-1, blaOXA-51, blaOXA-23 betalactamase genes. Clonal relatedness was estimated by PFGE with 
the restriction enzyme SmaI.
Results and Conclusion: Of 100 isolates of imipenem resistant Acinetobacter spp. collected from Tehran hospitals in 2009 
and 2010, 6 isolates produced metallo-beta-lactamases and 94 isolates produced OXA- type carbapenemase. The blaSPM-1, 
blaGES-1, blaOXA-51, blaOXA-23 genes were detected by PCR among 6, 2, 94 and 84 isolates of A. baumannii, respectively. The 
MICs of isolates to imipenem were 8–128 μg/mL. PFGE analysis of 29 blaOXA-51 and blaOXA-23-positive A. baumannii isolates 
gave 6 different patterns. This is the first report of SPM-1 and GES-1 beta-lactamase producing A. baumannii. Production 
of the OXA-23, OXA-51, GES-1 and SPM-1 enzyme presents an emerging threat of carbapenem resistance among A.   
baumannii in Iran.
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INTRODUCTION
Acinetobacter is an important cause of nosocomial 
infections and has been associated with a wide variety 
of illnesses in hospitalized patients, especially patients 
in the intensive care units (1). The clinical strains 
of A. baumannii are usually multidrug resistant to 
aminoglycosides, fluoroquinolones, ureidopenicillins 
and  third  generation  cephalosporins.  In  cases  of 
resistance to betalactams caused by extended spectrum 
β-lactamases  and  AmpC  enzyme,  carbapenems 
are often used as the last resort against infections. 
However, carbapenem- hydrolyzing- β-lactamases of 
molecular class B and D have emerged over the last 
decade (2).
Class B carbapenemases including IMP and VIM 
termed as metallo beta lactamases (MBLs) have been 
found so far in A. baumannii and these are encoded 
by different plasmid types (3). Class D (OXA) have 
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emerged as the major carbapenemases in the world. 
OXA enzyme (encoded by blaOXA genes) can be sub-
classified into eight subgroups, of which OXA-23-
like,  OXA-24-like,  OXA-51-like  and  OXA-58-like   
have been identified in A. baumannii. The blaOXA-51-
type genes are intrinsically harbored by A. baumannii 
isolates  (4).  Recently,  new  classes  of  betalactams 
including SPM-1, GIM-1, SIM, and AIM have also 
been  reported.  GES-2,  GES-4  and  GES-5  class A 
β-lactamases showed weak activity for hydrolysis  of 
imipenem (5).
The first  nosocomial outbreak with  carbapenem-
resistant A. baumannii) CRAB )was reported from 
the USA in 1991. Since then, CRAB infections and 
extensive  hospital  outbreaks  have  been  reported 
throughout  the  world  (6).  However,  despite  the 
worldwide  occurrence  of  epidemic  carbapenem 
resistance strains, metallo beta lactamase producing 
A. baumannii isolates have been found to be disseminat- 
ed  only  in  specific  geographic  areas  (7).  Gram 
negative bacilli producing acquired IMP, VIM and 
SPM-1 has been reported more in Asia and South 
America, respectively (8). Because of the importance 
of resistance to beta lactam antibiotics among clinical 
isolates,  understanding  the  underlying  genetic 
mechanisms  responsible  for  the  acquisition  and 
spread of unique beta lactamase-mediated antibiotic 
resistance  mechanism  could  eventually  facilitate 
the development of effective prevention and control 
measures (9).
Recent  studies  have  shown  the  existence  of 
different MBLs  producing clones of  A.  baumannii 
in Iran. The aims of this study were to determine the 
drug  susceptibility  patterns  of  Acinetobacter  spp. 
isolated from patients at different Tehran hospitals 
and to identify the genes encoding VIM, IMP, SPM 
and GES carbapenemase among the isolates. Pulsed-
Field  Gel  Electrophoresis  (PFGE)  was  then  used 
to  investigate  the  genetic  relationships  among  the 
isolates  and  possibility  of  intra-  and  inter-hospital 
spread of resistant strains. 
MATERIAlS  AND METHODS
Bacterial identification and susceptibility testing.
Two  hundred  and  three  non-repetitive  isolates  of 
Acinetobacter recovered from blood, wound, urine, 
sputum, and respiratory tract were obtained from 7 
hospitals in Tehran between May 2009 to September 
2010. The isolates were identified by conventional 
biochemical methods and confirmed by PCR assay 
targeting the blaOXA-51 like gene (10). 
All imipenem-resistant isolates were also tested in 
the Kirby Bauer method of disk diffusion to check 
their  susceptibilities  to  aztreonam  (ATM:  30  μg), 
amikacin  (AN:  30  μg),  cefepime  (CPM:  30  μg) 
cefotaxime (CTX: 30 μg), ceftazidime (CAZ: 30 μg), 
ceftriaxone (CRO: 30 μg), cefexime (CFM: 30 μg), 
ciprofloxacin  (CIP:  5  μg),  meropenem  (MEM:  10 
μg), imipenem (IMP: 10 μg), piperacillin (PRL: 100 
μg), piperacillin-tazobactam (PTZ: 110 μg), colistin 
(CL:  10  μg),  polymixinB  (PB:  300  unit)  (MAST, 
Merseyside,  U.K).  Multidrug  resistance  (MDR) 
was  defined  as  resistance  to  3  or  more  classes  of 
drugs that would otherwise serve as treatments for 
Acinetobacter infection (e.g., quinolones, cephalospo-
rins, and carbapenems) (11, 12).
Strains  found  resistant  to  imipenem  by  disk 
diffusion test were re-checked in broth micro dilution 
assay (Sinha et al., 2007). MIC for imipenem ranging 
from  0.25  µg/ml  through  128  µg/ml  was  tested. 
ATCC Pseudomonas aeruginosa 27853 was used as 
control strain. The MICs  ≥  8 µg/ml was interpreted 
as resistance to imipenem (13).
PCR assay. DNA template from imipenem resistant 
isolates (MIC ≥ 8 µg/ml) were extracted by boiling 
for 15 minutes and used as template in PCR assay 
to amplify blaVIM-2, blaSPM-1, blaIMP-2, blaGES-1, blaOXA-
51, blaOXA-23 genes by using thermocycler (Eppendorf, 
Hamburg,  Germany).  The  primers  described  by 
Shibata, Weldhagen and Woodford were used in this 
experiments (14, 15, 4). The reactions were initiated 
in  solution  containing  200  µM  concentrations  of 
dNTPs, 10 pM of each primer, 0.8 mM MgCl2, 0.5U 
Taq polymerase (Metabion, Martinsried, Germany) 
and 50 ng DNA template in a final volume of 25 µL.
A.  baumannii  AC54/97  producing  blaIMP  gene 
(16),  P.  aeruginosa  PO510  producing  blaVIM-1,  P. 
aeruginosa COL-1 producing blaVIM-2, P. aeruginosa 
16  producing  blaSPM-1  (Kindly  provided  by  P. 
Nordmann), K. pneumoniae ORI-1 producing blaGES-1, 
A. baumannii NCTC 13304 and A. baumannii NCTC 
# 12156 producing blaOXA-23 and blaOXA-51 were used 
as controls.
The amplicons were electrophoresed in 1% agarose 
gel  and  visualized  after  staining  with  ethidium 
bromide.  A  100  bp  ladder  (Fermentas,  Vilnius, 
Lithuania) was used as molecular weight marker. The 
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23 were purified on Qiaquick columns (QIAGEN, Ca, 
USA) and the sequencing was carried out using the 
ABI  capillary  system  (Macrogen  Research,  Seoul, 
Korea).
The nucleotide sequences of amplicons have been 
assigned to the Gene Bank under accession numbers 
HM370522, HM370523, HQ222987, HQ222988 for 
blaGES-1, blaSPM-1, blaOXA-51 and blaOXA-23 respectively.
plasmid  DNA  extraction  and  conjugation 
experiments.  Plasmid  DNAs  from  the  blaSPM  and 
blaGES positive strains of A. baumannii were extracted 
using the plasmid extraction kit (Qiagen, Courtaboeuf, 
France) and targeted for the blaSPM and blaGES-1 genes 
using  the  primers  described  previously.  Transfer 
of  resistance  by  conjugation  was  attempted  using 
A. baumannii (donor) and E. coli K12 (recipients). 
Overnight filter mating experiments were performed 
at  37ºC,  and  the  transconjugants  were  selected  on 
MacConkey  agar  and  plates  supplemented  with 
imipenem (16 μg/ml).
 
MBL screening. Screening for MBLs in selected 
isolates was performed with combined disk synergy 
test. In brief, disks containing 750 µg of EDTA plus 
10 µg of imipenem were placed on the inoculated 
plates containing Muller Hinton agar. An increase of 
≥ 17 mm in zone diameter in the presence of 750 µg 
of EDTA compared to imipenem alone indicated the 
presence of an MBL (9).
PFGE. The intact chromosomal DNAs from 29 
MDR imipenem-resistant Acinetobacter baumannii 
carrying  blaOXA-23  )MICIMP   ≥  8  µg/ml)  belonging 
to  the same antibiotype were extracted for PFGE 
as describ-ed by Durmaz et al. (17). These strains 
collected from 5 hospitals where the most collected 
isolate came from. The PUlseNet universal standard 
marker  strain  Salmonella  choleraesuis  serotype 
Branderup  H9812  was  used  as  a  molecular  size 
marker. The gels were stained with ethidium bromi-
de and DNA patterns were photographed with UVP 
gel Documentation (UVP, UK) (Fig. 1). The DNA 
banding patterns were analyzed using GelCompare 
II software (Apllied maths NV, St-Martens- Latem 
Beligum). PFGE DNA pattern was compared and 
interpreted according to criteria of Tenover et al. 
(18).
Statistical Analysis. Description and analysis of 
the data were carried out using SPSS 16.0 software. 
The nonparametric Mann-Whitney test was used for 
comparison between the different groups. A p-value   
≤ 0.05 was considered significant.
RESUlTS
Clinical  bacterial  strains.  Of  203  isolates  of 
Acinetobacter spp. cultured from clinical specimens, 
100  were  resistant  to  imipenem  by  disk  diffusion 
method and these were cultured from blood (47%), 
respiratory tract (24%), wound (12%), sputum (10%) 
and urine (7%). The results of broth microdilution 
assay showed high-level of resistance to imipenem. 
Most of the impenem- resistant isolates )n = 100) were 
also resistant to aztreonam (96%), amikacin (84%), 
cefepime (90%), cefotaxime (98%), ceftazidime (86%), 
ceftriaxone  (99%),  cefexime  (100%),  ciprofloxacin 
(84%),  meropenem  (100%),  piperacillin  (96%), 
piperacillin-tazobactam  (95%),  colistin  (12%)  and 
polymixinB (3%). Totally 83 isolates were recognized 
as MDR (Multi Drug Resistance). Taking the MICs 
of ≥ 8 µg/mL as resistant, all studied isolates were 
resistant  to  imipenem. An  MIC  =  64  µg/mL  was 
found among 47% of MDR isolates. 
A  total  of  100  selected  isolates  were  examined 
for  MBL  profiles  by  the  combined-disk  method. 
This method showed that 9% of isolates were able 
to produce MBLs, of which 6 strains were identified 
as A. baumannii and 3 isolates belonged to the other 
species of Acinetobacter.
Using  PCR  assay,  94%  and  84%  of  the  isolates 
were positive for blaOXA-51 and blaOXA-23 like genes 
respectively. Of 100 isolates tested, 6 strains (ABI/30, 
ABI/41, ABI/43, ABI/51, ABI/58 and ABI/70) and 
2  strains  (ABI/43  and  ABI/51)  appeared  to  carry 
blaSPM-1  and  blaGES-1  respectively  (Table  1).  The 
blaVIM-2 and blaIMP genes were not detected among the 
studied isolates.
All of the blaSPM positive isolates were collected   
from different hospitals and their antibiogram indicat-
ed that our studied isolates were resistant to all studi-
ed antibiotic except polymixin B and colistin. Only 
two  isolates  (ABI/43  and  ABI/51)  carried  blaSPM, 
blaGES, blaOXA-51and blaOXA-23 simultaneously (Table. 1).
plasmid  DNA  extraction,  conjugation  experi-
ments. PCR results show that blaSPM-1 and bla  GES-1 
are carried by plasmid. Our experiments for conjugal 
transformation of plasmid did not give any result.71 AcinetobActer bAumAnnii pRODUCING METAllO-B-lACTAMASE 
ATM CRO CpM AN CAZ CIp CTX pRl MEM IMp CFM CpTZ Cl pB OXA-
51,23 SpM GES
ABI/30 D R R R   S   R R R  R R  R R R S S ≥128 + + -
ABI/41 A R R R S   R R R  R R  R R R S S 64 + + -
ABI/43 C R R R  S   R R R  R R  R R R S S 64 + + +
ABI/51 A R R R  S   R R R  R R  R R R S S 64 + + +
ABI/58 A R R R   S   R R R  R R  R R R S S 64 + + -
ABI/70 A R R R   S   R R R  R R  R R R S S 64 + +  -
Table 1. Characterization of blaSPM-1 and blaGES-1 positive Acinetobacter clinical isolates. 
Name of Hospital                       Antibiotic resistance                                                           MICIMPμg/ml                PCR        I    Isolates
“Abbreviations:  ATM = Aztereonam, CRO = Ceftriaxone, CPM = Cefepime, AN = Amikacin, CAZ = Ceftazidime, CIP = Ciprofloxacin, 
CTX = Cefotaxime, PRL = Pipercillin, MEM = Meropenem, IMP = Imipenem, CFM = Cefexime, PTZ = Pipercillin- tazobactam, Cl = 
Colistin, PB = Plolymixin B
Fig. 1. Dendrogram of the six (A-F) pulsed field gel electrophoresis profile of Smal-digested genomic DNAfrom 26 blaOXA-23 
positive A. baumannii isolates were from hospital A to E.72 SHAHCHERAGHI  ET AL .                                                                                                   IRAN. J. MICROBIOL. 3 (2) : 68-74 
Sequencing. Aligning of the obtained sequences 
with those of reference strains in Gene Bank confirm-
ed  the  correct  identification  of  blaGES-1,  blaSPM-1, 
blaOXA-51 and blaOXA-23 by PCR. 
PFGE  analysis.  Totally,  29  isolates  with  MDR 
phenotype were analyzed by PFGE and these were 
collected from hospitals A (n = 13), B (n = 7), C (n = 6), 
D (n = 2) and E (n = 1). They showed co-resistance to 
antimicrobial agents including amikacin, aztreonam, 
piperacillin,  piperacillin–tazobactam,  ceftazidime, 
cefepime,  cefexime,  cefotaxime,  cefteriaxone, 
ciprofloxacin, meropenem, polymyxin B and colistin. 
Genotyping identified 6 distinct pulsotypes allocated 
as A to F among 5 hospitals (Fig. 1). The pulsotypes 
A, B and C were the dominant types found in the 
hospitals. Conversely, pulsotypes D, E and F each 
contained single isolate. The pulsotype A consisted 
of 19 isolates. They were differentiated into closely 
related pattern comprising of patterns A1–A10 (Fig. 
1).  Isolates  from  hospital  A  were  heterogeneous 
since  7  different  banding  patterns  were  found  for 
13 isolates. More diversity were found among the 
isolates at hospitals B (n = 7) and C (n = 6) since 6 and 
4 pulsotypes were found among the isolates of these 
hospitals respectively (Fig. 1). Six SPM-1- producing 
and two GES-1-producing isolates produced closely 
related patterns.
DISCUSSION
This  is  the  first  report  on  the  existence  of 
blaSPM-1  and  blaGES-1  among  the  clinical  strains  of 
A. baumannii in Iran. Occurrence of SPM-1 MBL 
among  P.  aeruginosa  has  been  described  among 
clinical isolates in Brazil. SPM-1 is distinct from VIM 
and IMP and represents a new subfamily of mobile 
MBL which is carried on a plasmid. This is important 
since it can transform both E. coli and P. aeruginosa 
to ceftazidime resistance (19). Detection of GES-1 
among the Iranian strains of A. baumannii is another 
important finding of the current study. This ESBL 
enzyme  was  initially  described  from  a  Klebsiella 
pneumoniae strain in 1998. GES-1 is weakly related 
to the other Ambler class A β-lactamases, particularly 
to  the  plasmid-located  ESBLs  so  far  identified 
in  Enterobacteriacae.  However,  GES-1  may  be 
classified rather as a ceftazidime-hydrolyzing enzyme 
(20). Our survey showed that these two genes can not 
be transferred to E. coli K12 strain by conjugation. 
While  IMP-2  is  reported  in  A.  baumannii  from 
Italy and Japan, VIM enzymes have been identified 
very  rarely  in  A.  baumannii,  being  represented 
only  by  VIM-2  reported  in  South  Korea.  Despite 
carbapenemase  activity  of  resistant  strains,  these 
MBL genes have not been detected in A. baumannii 
from Iran (21). Among MBL genes, only VIM-type 
had been detected in P. aeruginosa in Iran (16).
The MBLs can hydrolyze all beta-lactams except 
aztreonam.  However,  all  MBL  producing  isolates 
in our study were resistant to aztreonam too. Other 
mechanisms such as ESBL production, efflux pumps 
and  hyper-production  of  cephalosporinase  possibly 
are  involved  in  resistance  to  aztreonam  in  our 
collection of isolates.
This study showed low susceptibility rates to most 
of the clinically available antimicrobial agents for the 
treatment of infections caused by Acinetobacter spp.   
except  for  polymyxin B  and  colistin.  This  finding 
suggests  both  of  them  as  therapeutic  options  for 
the treatment of infections caused by these isolates. 
Among imipenem resistant isolates, 94% harboured 
at  least  one  acquired  class  D  carbapenemase-
encoding  gene.  Therefore,  the high  prevalence  of 
class  D  carbapenemase-encoding  genes  among the 
clinical  isolates  from  Iran  appears  responsible for 
low susceptibility rates for imipenem [P < 0.05; sig = 
0.002]. According to the SENTRY report distribution 
of  OXA-type  genes  among  Acinetobacter  spp. 
isolates in Asia-Pacific nations was comprised mainly 
of blaOXA-23, while blaOXA-24/40 and blaOXA-58 were less 
common. In addition, clonal dissemination was found 
among different medical centers in different countries 
in the Asia-Pacific region (22). In our study, blaOXA-23 
was the most common genes encoding carbapenamase 
at Tehran hospitals. 
PFGE  analysis revealed genetic diversity among           
the MDR A. baumannii isolates. These results may 
support the assumption that MDR strains are emerged 
more by horizontal transfer of MBL genes among 
different  phenotypic  clones  of  Acinetobacter.  Six 
SPM-1- producing and two GES-1-producing isolates 
showed closely related patterns. Such a correspondence 
of  phenotypic  and  genotypic  characteristic  can  be 
attributed to a common clonal origin. Some isolates 
that gave identical typing results had been isolated 
from patients of different hospitals at different times. 
Therefore, these types have simultaneous presence 
and genetically are stable in community. Moreover, 
a few of these isolates showed different antimicrobial 73 AcinetobActer bAumAnnii pRODUCING METAllO-B-lACTAMASE 
susceptibility  patterns.  This  caused  by  transfer  of 
these antibiotic resistance genes to the similar clonal 
strains  through  transformation  or  conjugation. The 
possibility of inter-hospital transmission of potentially 
pathogenic  bacteria  including  P.  aeruginosa  has 
already been debated in Iran (23).
In conclusion, the rate of resistance to betalactams 
was  high  in  our  study.  Since  the  rate  of  isolates 
carrying blaSPM-1and blaGES-1 was very low, it seems 
that other mechanisms such as decreased permeability, 
over  expression  of  efflux  pump,  production  of 
carbapenemases probably are involved in resistance 
to  betalactams.  Understanding  the  underlying 
genetic mechanisms responsible for the acquisition 
and spread of this unique beta lactamase mediated 
antibiotic  resistance  mechanism  could  eventually 
facilitate the development of effective prevention and 
control strategies and thereby allowing more effective 
drug usage and treatment of disease, and reducing 
resistance development (9).
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